🟢 Picard Medical is trading 18.91% up today after Q2 revenue nearly doubled analyst consensus

Picard Medical is trading 18.91% up now at $6.10 after investors continued repricing the stock following second-quarter results.

• Revenue reached approximately $2.95 million, nearly double the roughly $1.55 million analyst consensus.
• The company reported a wider-than-expected $3.05 per-share loss, versus estimates of $1.50.
• The rally follows a 59.81% gain on August 24 and reflects strong revenue momentum despite substantial cash-burn concerns.